psychiatric disease; behavioral disorder
Jump to navigation
Jump to search
Clinical manifestations
- psychiatric disease manifests itself through behavioral disturbances
Laboratory
- higher leukocyte count associated with increased risk*
- higher serum C-reactive protein associated with increased risk*
- higher serum haptoglobin associated with increased risk*
- higher IgG associated with lower risk*
* laboratory associatios with risk of psychiatric disease
Complications
- persons with one psychiatric disorder are more likely to have another[6]
- decreased life expectancy (all psychiatric diseases)
- 13.5-15.9 years in men
- 10.4-12.0 years in women
- decrease greatest for alcoholism & drug abuse
- chronic disease (cardiovascular disease, cancer ...) account for 75% of decrease
- suicide accounts for 14% of the decrease[1]
Management
- exercise via cybercycling integrated into physical education improves classroom functioning among children with behavioral disorders attending a therapeutic day school[4]
- use of calcium-channel blockers, & metformin each associated with lower risk for psychiatric hospitalizations among all mental illness subgroups[5]*
- self-harm risk lower with calcium-channel blocker use in all mental illness subgroups, & with statin & metformin use in patients with bipolar disorder & schizophrenia[5]*
* adjusted hazzard ratios statistically significant, but modest & of unclear clinical significance (swedish study)
More general terms
More specific terms
- addiction (psychological dependence)
- cataplexy
- conduct disorder
- critical illness neuropsychiatric impairment (post-ICU neuropsychiatric impairment)
- delusional disorder
- dissociative disorder
- factitious disorder
- feigning of symptoms
- hoarding
- impulse control disorder
- Morgellons disease
- neurosis
- paraphilia
- paraphrenia
- pathologic lying
- pediatric acute-onset neuropsychiatric syndrome (PANS)
- personality disorder
- psychogenic movement disorder; psychomotor disorder
- psychological trauma
- psychosis
- schizophrenia
- somatoform (psychosomatic) disorder; somatic symptom & related disorders (SSRD)
- stereotypy/habit disorder
- suicide
- suicide attempt
Additional terms
References
- ↑ 1.0 1.1 Lawrence D et al. The gap in life expectancy from preventable physical illness in psychiatric patients in western australia: retrospective analysis of population based registers. BMJ 2013 May 21; 346:f2539. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23694688
- ↑ Huhn M et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry 2014 apr 30 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24789675 <Internet> http://archpsyc.jamanetwork.com/article.aspx?articleid=1865002
Correll CU, Carbon M. Efficacy of pharmacologic and psychotherapeutic interventions in psychiatry: to talk or to prescribe: is that the question? JAMA Psychiatry 2014 apr 30 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24789579 <Internet> http://archpsyc.jamanetwork.com/article.aspx?articleid=1865001 - ↑ Montross C Hard time or hospital treatment? Mental illness and the criminal justice system. N Engl J Med 2016; 375:1407-1409. october 13, 2016 http://www.nejm.org/doi/full/10.1056/nejmp1606083
- ↑ 4.0 4.1 Bowling A, slavet j, miller dp et al Cybercycling effects on classroom behavior in children with behavioral health disorders: an rct. pediatrics. january 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28069663 <Internet> http://pediatrics.aappublications.org/content/early/2017/01/05/peds.2016-1985
- ↑ 5.0 5.1 5.2 Jayes JF, lundin a, wicks s et al Association of hydroxylmethyl glutaryl coenzyme a reductase inhibitors, l-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization and self-harm in individuals with serious mental illness. JAMA Psychiatry published online january 9, 2019. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30624557 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2719703
- ↑ 6.0 6.1 Plana-Ripoll O, Pedersen CB, Holtz Y et al. Exploring comorbidity within mental disorders among a danish national population. JAMA Psychiatry 2019 jan 16; PMID: https://www.ncbi.nlm.nih.gov/pubmed/30649197
Hyman SE. New evidence for shared risk architecture of mental disorders. JAMA Psychiatry2019 jan 16 pmid: https://www.ncbi.nlm.nih.gov/pubmed/30649144 - ↑ Zeng Y, Chourpiliadis C, Hammar N et al Inflammatory biomarkers and risk of psychiatric disorders. JAMA Psychiatry. 2024 aug 21:e242185. pmid: https://www.ncbi.nlm.nih.gov/pubmed/39167384 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2822344
- ↑ Ardila A. Psychiatric disorders associated with acquired brain pathology. Appl Neuropsychol Adult. 2019;26(6):591-597 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30183352 Review. https://www.tandfonline.com/doi/full/10.1080/23279095.2018.1463224